GenScript Biotech, the world's leading life-science research tools and services provider, and T-MAXIMUM Biotech, a biotechnology company pioneering univers...
Poseida is a clinical-stage biotechnology company dedicated to advancing a new class of cancer cell therapy and gene therapy products using genetic enginee...
New research looking at the mental health and eating behaviours of patients 1-year after bariatric surgery has found that a short, 7-session telephone cogn...
BLUEMOTH, a pioneer in consumer-first hearing wellness, announced the launch of a virtual destination that gives users the freedom to discover and sh...
The Synaptive MRI is a 0.5T system that was designed to overcome challenges such as accessibility in critical and acute cases like brain tumour and stroke,...
MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, de...
Melinta Therapeutics, LLC announced the availability of REZZAYO™ (rezafungin for injection), for the treatment of candidemia and invasive candi...
Acquisition aims to strengthen BioNTech’s pioneering position in the field of AI-powered drug discovery, design and development InstaDeep to opera...
Transaction brings Qunol®, a trusted, profitable double-digit growth and market-leading brand in health & wellness to Sanofi’s CHC U.S. por...
Hyro, the leader in conversational artificial intelligence (AI) for healthcare, today announced a partnership with Gozio Health, an industry-leading, custo...
India based Lupin Digital Health and the American College of Cardiology (ACC) have announced a first-of-its-kind collaboration to deliver in-home cardiovas...
Collaboration Combines ImmunoGen's Proprietary Linker-Payload Technology with Antibodies Developed by ImmunoBiochem Agreement Grants ImmunoGen an Exclusiv...
Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, today announced the launch of PERCLOT Absorbable Hemostatic Powder ...
Each year in Europe more than 550,000 patients are diagnosed with breast cancer, of whom 70% have estrogen receptor (ER)-positive disease¹; more tha...
© 2025 Biopharma Boardroom. All Rights Reserved.
